| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 15.032 | 29.015 | 19.999 | 3.339 | 16.115 | 21.330 | 20.940 |
| Total Income - EUR | - | - | - | 15.032 | 29.015 | 19.999 | 3.339 | 16.115 | 21.330 | 20.940 |
| Total Expenses - EUR | - | - | - | 2.471 | 3.987 | 1.318 | 688 | 563 | 568 | 582 |
| Gross Profit/Loss - EUR | - | - | - | 12.560 | 25.028 | 18.681 | 2.651 | 15.552 | 20.762 | 20.358 |
| Net Profit/Loss - EUR | - | - | - | 12.410 | 24.383 | 18.113 | 2.550 | 15.079 | 17.507 | 17.158 |
| Employees | - | - | - | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Danmed Path S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 13.537 | 25.515 | 42.738 | 43.730 | 15.736 | 18.766 | 18.932 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 10.970 | 23.364 | 41.365 | 42.541 | 15.142 | 16.138 | 15.422 |
| Cash | - | - | - | 2.568 | 2.151 | 1.372 | 1.189 | 594 | 2.628 | 3.510 |
| Shareholders Funds | - | - | - | 12.453 | 24.433 | 42.083 | 43.700 | 15.128 | 17.555 | 17.207 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.084 | 1.082 | 654 | 30 | 609 | 1.210 | 1.726 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Danmed Path S.r.l.